Fidaxomicin has shown promise as an effective treatment option for Clostridium difficile infections, but no pharmacoeconomic studies have been performed to date.
Jason W. Lancaster, PharmD, BCPS
Advertisement
Articles by Jason W. Lancaster, PharmD, BCPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves XFG-Adapted COVID-19 Vaccine, mRNA for the 2026-2027 Season
2
Beyond the Transplant Center: IV Therapy in the Community
3
Incorporating Patient-Reported Symptoms into Treatment Plans
4
Safety Monitoring Protocols During Transitions of Care
5